Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping

Alexander Tischer, Venkata R. Machha, Juan P. Frontroth, Maria A. Brehm, Tobias Obser, Reinhard Schneppenheim, Leland Mayne, S. Walter Englander, Matthew T Auton

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Mutation of the cysteines forming the disulfide loop of the platelet GPIbα adhesive A1 domain of von Willebrand factor (VWF) causes quantitative VWF deficiencies in the blood and von Willebrand disease. We report two cases of transient severe thrombocytopenia induced by DDAVP treatment. Cys1272Trp and Cys1458Tyr mutations identified by genetic sequencing implicate an abnormal gain-of-function phenotype, evidenced by thrombocytopenia, which quickly relapses back to normal platelet counts and deficient plasma VWF. Using surface plasmon resonance, analytical rheology, and hydrogen–deuterium exchange mass spectrometry (HXMS), we decipher mechanisms of A1-GPIbα-mediated platelet adhesion and resolve dynamic secondary structure elements that regulate the binding pathway. Constrained by the disulfide, conformational selection between weak and tight binding states of A1 takes precedence and drives normal platelet adhesion to VWF. Less restrained through mutation, loss of the disulfide preferentially diverts binding through an induced-fit disease pathway enabling high-affinity GPIbα binding and firm platelet adhesion to a partially disordered A1 domain. HXMS reveals a dynamic asymmetry of flexible and ordered regions common to both variants, indicating that the partially disordered A1 lacking the disulfide retains native-like structural dynamics. Both binding mechanisms share common structural and thermodynamic properties, but the enhanced local disorder in the disease state perpetuates high-affinity platelet agglutination, characteristic of type 2B VWD, upon DDAVP-stimulated secretion of VWF leading to transient thrombocytopenia and a subsequent deficiency of plasma VWF, characteristic of type 2A VWD.

Original languageEnglish (US)
Pages (from-to)2161-2177
Number of pages17
JournalJournal of Molecular Biology
Volume429
Issue number14
DOIs
StatePublished - Jul 7 2017

Fingerprint

von Willebrand Factor
Blood Platelets
Disulfides
Thrombocytopenia
von Willebrand Diseases
Deamino Arginine Vasopressin
Mutation
Mass Spectrometry
Surface Plasmon Resonance
Rheology
Agglutination
Platelet Count
Thermodynamics
Adhesives
Cysteine
Phenotype
Recurrence

Keywords

  • GPIbα
  • hydrogen–deuterium exchange mass spectrometry
  • Von Willebrand disease
  • Von Willebrand factor

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping. / Tischer, Alexander; Machha, Venkata R.; Frontroth, Juan P.; Brehm, Maria A.; Obser, Tobias; Schneppenheim, Reinhard; Mayne, Leland; Walter Englander, S.; Auton, Matthew T.

In: Journal of Molecular Biology, Vol. 429, No. 14, 07.07.2017, p. 2161-2177.

Research output: Contribution to journalArticle

Tischer, A, Machha, VR, Frontroth, JP, Brehm, MA, Obser, T, Schneppenheim, R, Mayne, L, Walter Englander, S & Auton, MT 2017, 'Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping', Journal of Molecular Biology, vol. 429, no. 14, pp. 2161-2177. https://doi.org/10.1016/j.jmb.2017.05.013
Tischer, Alexander ; Machha, Venkata R. ; Frontroth, Juan P. ; Brehm, Maria A. ; Obser, Tobias ; Schneppenheim, Reinhard ; Mayne, Leland ; Walter Englander, S. ; Auton, Matthew T. / Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping. In: Journal of Molecular Biology. 2017 ; Vol. 429, No. 14. pp. 2161-2177.
@article{381c2654d7654e119cffbbd702ce25ce,
title = "Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping",
abstract = "Mutation of the cysteines forming the disulfide loop of the platelet GPIbα adhesive A1 domain of von Willebrand factor (VWF) causes quantitative VWF deficiencies in the blood and von Willebrand disease. We report two cases of transient severe thrombocytopenia induced by DDAVP treatment. Cys1272Trp and Cys1458Tyr mutations identified by genetic sequencing implicate an abnormal gain-of-function phenotype, evidenced by thrombocytopenia, which quickly relapses back to normal platelet counts and deficient plasma VWF. Using surface plasmon resonance, analytical rheology, and hydrogen–deuterium exchange mass spectrometry (HXMS), we decipher mechanisms of A1-GPIbα-mediated platelet adhesion and resolve dynamic secondary structure elements that regulate the binding pathway. Constrained by the disulfide, conformational selection between weak and tight binding states of A1 takes precedence and drives normal platelet adhesion to VWF. Less restrained through mutation, loss of the disulfide preferentially diverts binding through an induced-fit disease pathway enabling high-affinity GPIbα binding and firm platelet adhesion to a partially disordered A1 domain. HXMS reveals a dynamic asymmetry of flexible and ordered regions common to both variants, indicating that the partially disordered A1 lacking the disulfide retains native-like structural dynamics. Both binding mechanisms share common structural and thermodynamic properties, but the enhanced local disorder in the disease state perpetuates high-affinity platelet agglutination, characteristic of type 2B VWD, upon DDAVP-stimulated secretion of VWF leading to transient thrombocytopenia and a subsequent deficiency of plasma VWF, characteristic of type 2A VWD.",
keywords = "GPIbα, hydrogen–deuterium exchange mass spectrometry, Von Willebrand disease, Von Willebrand factor",
author = "Alexander Tischer and Machha, {Venkata R.} and Frontroth, {Juan P.} and Brehm, {Maria A.} and Tobias Obser and Reinhard Schneppenheim and Leland Mayne and {Walter Englander}, S. and Auton, {Matthew T}",
year = "2017",
month = "7",
day = "7",
doi = "10.1016/j.jmb.2017.05.013",
language = "English (US)",
volume = "429",
pages = "2161--2177",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "14",

}

TY - JOUR

T1 - Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping

AU - Tischer, Alexander

AU - Machha, Venkata R.

AU - Frontroth, Juan P.

AU - Brehm, Maria A.

AU - Obser, Tobias

AU - Schneppenheim, Reinhard

AU - Mayne, Leland

AU - Walter Englander, S.

AU - Auton, Matthew T

PY - 2017/7/7

Y1 - 2017/7/7

N2 - Mutation of the cysteines forming the disulfide loop of the platelet GPIbα adhesive A1 domain of von Willebrand factor (VWF) causes quantitative VWF deficiencies in the blood and von Willebrand disease. We report two cases of transient severe thrombocytopenia induced by DDAVP treatment. Cys1272Trp and Cys1458Tyr mutations identified by genetic sequencing implicate an abnormal gain-of-function phenotype, evidenced by thrombocytopenia, which quickly relapses back to normal platelet counts and deficient plasma VWF. Using surface plasmon resonance, analytical rheology, and hydrogen–deuterium exchange mass spectrometry (HXMS), we decipher mechanisms of A1-GPIbα-mediated platelet adhesion and resolve dynamic secondary structure elements that regulate the binding pathway. Constrained by the disulfide, conformational selection between weak and tight binding states of A1 takes precedence and drives normal platelet adhesion to VWF. Less restrained through mutation, loss of the disulfide preferentially diverts binding through an induced-fit disease pathway enabling high-affinity GPIbα binding and firm platelet adhesion to a partially disordered A1 domain. HXMS reveals a dynamic asymmetry of flexible and ordered regions common to both variants, indicating that the partially disordered A1 lacking the disulfide retains native-like structural dynamics. Both binding mechanisms share common structural and thermodynamic properties, but the enhanced local disorder in the disease state perpetuates high-affinity platelet agglutination, characteristic of type 2B VWD, upon DDAVP-stimulated secretion of VWF leading to transient thrombocytopenia and a subsequent deficiency of plasma VWF, characteristic of type 2A VWD.

AB - Mutation of the cysteines forming the disulfide loop of the platelet GPIbα adhesive A1 domain of von Willebrand factor (VWF) causes quantitative VWF deficiencies in the blood and von Willebrand disease. We report two cases of transient severe thrombocytopenia induced by DDAVP treatment. Cys1272Trp and Cys1458Tyr mutations identified by genetic sequencing implicate an abnormal gain-of-function phenotype, evidenced by thrombocytopenia, which quickly relapses back to normal platelet counts and deficient plasma VWF. Using surface plasmon resonance, analytical rheology, and hydrogen–deuterium exchange mass spectrometry (HXMS), we decipher mechanisms of A1-GPIbα-mediated platelet adhesion and resolve dynamic secondary structure elements that regulate the binding pathway. Constrained by the disulfide, conformational selection between weak and tight binding states of A1 takes precedence and drives normal platelet adhesion to VWF. Less restrained through mutation, loss of the disulfide preferentially diverts binding through an induced-fit disease pathway enabling high-affinity GPIbα binding and firm platelet adhesion to a partially disordered A1 domain. HXMS reveals a dynamic asymmetry of flexible and ordered regions common to both variants, indicating that the partially disordered A1 lacking the disulfide retains native-like structural dynamics. Both binding mechanisms share common structural and thermodynamic properties, but the enhanced local disorder in the disease state perpetuates high-affinity platelet agglutination, characteristic of type 2B VWD, upon DDAVP-stimulated secretion of VWF leading to transient thrombocytopenia and a subsequent deficiency of plasma VWF, characteristic of type 2A VWD.

KW - GPIbα

KW - hydrogen–deuterium exchange mass spectrometry

KW - Von Willebrand disease

KW - Von Willebrand factor

UR - http://www.scopus.com/inward/record.url?scp=85020011477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020011477&partnerID=8YFLogxK

U2 - 10.1016/j.jmb.2017.05.013

DO - 10.1016/j.jmb.2017.05.013

M3 - Article

C2 - 28533135

AN - SCOPUS:85020011477

VL - 429

SP - 2161

EP - 2177

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 14

ER -